Tag: aortoiliac
iVascular announces first data from BARISTA trial of Restorer BMS in...
iVascular has announced the first clinical outcomes of the Restorer bare metal stent (BMS) in iliac artery treatment.
The data were presented earlier this...
First patients enrolled in Gore’s VBX FORWARD clinical study
Gore has announced that the first patients have been enrolled in the Gore VBX FORWARD clinical study, a global prospective, multicentre, randomised controlled trial...
Gore initiates EMBRACE registry to evaluate VBX stent graft as bridging...
W L Gore & Associates today announced that it is initiating the EMBRACE registry to capture real-world data about the Gore Viabahn VBX balloon...
“A very grey area”: EVOCC trial addresses best treatment option for...
Athanasios Saratzis (University of Leicester, Leicester, UK) speaks to Vascular News about the EVOCC trial, which he hopes will dispel patient and physician “uncertainty”...
Medtronic announces first enrolment in head-to-head global randomised trial evaluating durability...
Medtronic has announced the first patient enrolment in the ADVANCE trial, a head-to-head randomised controlled trial of two leading aortic stent graft systems, the...
iVascular announces first patients enrolled in BARISTA clinical trial
iVascular recently announced the first patient enrolment in the BARISTA study, a Belgian physician-initiated study to assess the efficacy and safety of the company's...
New data support covered stent use in complex aortoiliac occlusive disease...
One-year outcomes from the BELSTREAM trial add to a growing pool of data that covered stents are safe and effective in the treatment of...
Long-term positive outcomes of Getinge’s Advanta V12 reinforced in systematic literature...
The reliable outcomes of Getinge’s Advanta V12 have been reinforced by a new systematic literature review. A group of physicians from around the world...
